- Fund Type: Closed-End Fund
- Objective: Government/Corporate
- Asset Class: Debt
- Geographic Focus: India
ICICI Prudential FMP - Series 63 - 3 Year Plan H
+ Add to WatchlistP633HRG:IN
10.0000 INR 0.00000.00%As of 12:11:10 ET on 05/21/2013.
Snapshot for ICICI Prudential FMP - Series 63 - 3 Year Plan H (P633HRG)
| Open: | 10.0000 | High - Low: | 10.0000 - 10.0000 | Primary Exchange: | BSE India |
|---|---|---|---|---|---|
| Volume: | 0 | 52-Week Range: | 10.0000 - 10.0000 | Beta vs SENSEX: | - |
Fund Profile & Information for P633HRG
ICICI Prudential FMP - Series 63 - 3 Year Plan H is an close-end fund incorporated in India. The Fund's objective is to seek to generate income by investing in a portfolio of fixed-income securities/debt instruments maturing on or before the maturity of the scheme.
| Inception Date: | 2012-04-25 | Telephone: | 91-22-2642 8000 |
|---|---|---|---|
| Managers: | CHAITANYA PANDE | ||
| Web Site: | www.icicipruamc.com | ||
Fundamentals for P633HRG
| NAV | (on 2013-05-21) 11.1600 |
|---|---|
| Assets (M) | (on 2013-03-29) 2,466.1950 |
| Shares out (M) | 214.25 |
| Market Cap (M) | 2,142.48 |
| % Premium | -10.40 |
| Average 52-Week % Premium | -4.9471 |
| Fund Leveraged | N |
Dividends for P633HRG
No dividends reported
Performance for P633HRG
| 1-Month | 0.00% | 1-Year | 0.00% |
|---|---|---|---|
| 3-Month | 0.00% | 3-Year | - |
| Year To Date | 0.00% | 5-Year | - |
| Expense Ratio | - |
Top Fund Holdings for P633HRG
Filing Date: 03/31/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| TCFSIN 0 05/04/15 | 452,000 | 496,864,000 | 20.147% |
| MMFSIN 0 05/04/15 | 595,000 | 493,735,000 | 20.020% |
| BAFIN 0 05/04/15 | 437,000 | 480,243,000 | 19.473% |
| KMBIN 10 04/05/15 | 447,000 | 451,013,000 | 18.288% |
| SUFIN 0 04/30/15 | 400,000 | 332,248,000 | 13.472% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page